Friendly” labels on the packaging are becoming more common as a growing number of Americans try obesity drugs like Wegovy and ...
Eli Lilly's research and development head said on Monday the company will have plenty of supply to launch its ...
Weight-loss drug developer Viking Therapeutics CEO said on Monday that strategic interest in weight-loss drug deals is ...
Federal regulators are telling drugmakers to remove label warnings about potential suicidal thoughts and behaviors from their ...
Clinical trials show retatrutide, Eli Lilly's new triple-agonist drug, delivered 24.2% weight loss in 48 weeks and the ...
Everyone should be eating protein, but Dr. Sowa says it’s "very, very important" when you’re on a weight loss journey. “It’s ...
The U.S. health regulator asked drugmakers on Tuesday to remove warnings about a potential risk of suicidal thoughts from ...
Weight-loss experts reveal their major predictions for 2026, from advanced GLP-1 treatments to AI-driven personalized therapy ...
For years, she seemed powerless against a fluctuating weight problem, until new medications, and a new attitude, gave Oprah ...
The medication, available at a lower cost, is an alternative to injections and increases accessibility for patients, some ...
His discovery of the protein fragment GLP-1 was crucial in the development of Ozempic, Wegovy and other blockbuster obesity ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results